Cargando…

COVID-19 and the nicotinic cholinergic system

The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S

Detalles Bibliográficos
Autores principales:	Farsalinos, Konstantinos, Angelopoulou, Athina, Alexandris, Nikos, Poulas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248130/ https://www.ncbi.nlm.nih.gov/pubmed/32444400 http://dx.doi.org/10.1183/13993003.01589-2020

Ejemplares similares

Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
por: Angelopoulou, Athina, et al.
Publicado: (2020)

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020)

Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021)

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020)

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond
por: Hasanagic, Senad, et al.
Publicado: (2020)

Corticosteroids in COVID-19: one size does not fit all
por: Gogali, Athena, et al.
Publicado: (2021)

Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health
por: Isik Andrikopoulos, Gozde, et al.
Publicado: (2019)

Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
por: Tanmay, Saraiya, et al.
Publicado: (2021)

COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020)

Healthcare workers with COVID-19 in Mexico
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
por: Seren, Seda, et al.
Publicado: (2021)

Face masks, respiratory patients and COVID-19
por: Soriano, Joan B., et al.
Publicado: (2020)

The (in)significance of TB and COVID-19 co-infection
por: Khurana, Alkesh Kumar, et al.
Publicado: (2020)

Correlation and causality: a COVID-19 conundrum
por: Morice, Alyn H.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020)

Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020)

COVID-19 in Italy: passing through bitter waters
por: Guglielmetti, Lorenzo, et al.
Publicado: (2020)

Arterial hypertension and the risk of severity and mortality of COVID-19
por: Leiva Sisnieguez, Carlos Enrique, et al.
Publicado: (2020)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

Reply: Is high-dose glucocorticoid beneficial in COVID-19?
por: Edalatifard, Maryam, et al.
Publicado: (2021)

Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure
por: Galambos, Csaba, et al.
Publicado: (2021)

Between inflammation and thrombosis: endothelial cells in COVID-19
por: Birnhuber, Anna, et al.
Publicado: (2021)

Response to McMahon et al's “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases”
por: Poulas, Konstantinos, et al.
Publicado: (2022)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
por: O'Carroll, Orla, et al.
Publicado: (2020)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

To compare the incomparable: COVID-19 pneumonia and high-altitude disease
por: Strapazzon, Giacomo, et al.
Publicado: (2020)

Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
por: Salton, Francesco, et al.
Publicado: (2020)

Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
por: Aggarwal, Deepak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hfgp7ts5fo3u7u5fi9gessn8r0